Zobrazeno 1 - 10
of 960
pro vyhledávání: '"KAZUO KIMURA"'
Autor:
Satoshi Takeuchi, Satoshi Honda, Kensaku Nishihira, Sunao Kojima, Misa Takegami, Yasuhide Asaumi, Mike Saji, Jun Yamashita, Kiyoshi Hibi, Jun Takahashi, Yasuhiko Sakata, Morimasa Takayama, Tetsuya Sumiyoshi, Hisao Ogawa, Kazuo Kimura, Satoshi Yasuda, JAMIR Investigators
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2344-2353 (2024)
Abstract Aims The incidence and prognosis of symptomatic heart failure following acute myocardial infarction (AMI) in the primary percutaneous coronary intervention era have rarely been reported in the literature. This study aimed to (i) determine th
Externí odkaz:
https://doaj.org/article/a413c3f7ce1b4b9c8ec55aff0ee3425e
Autor:
Shin Ito, Hiroyuki Takahama, Masanori Asakura, Yukio Abe, Masayoshi Ajioka, Toshihisa Anzai, Takuo Arikawa, Takaharu Hayashi, Yorihiko Higashino, Shinya Hiramitsu, Noriaki Iwahashi, Chisato Izumi, Kazuo Kimura, Koichiro Kinugawa, Hidetaka Kioka, Young-Jae Lim, Ken Matsuoka, Satoshi Matsuoka, Hirohiko Motoki, Sunao Nakamura, Takafumi Nakayama, Akihiro Nomura, Taishi Sasaoka, Shin Takiuchi, Shigeru Toyoda, Tomoya Ueda, Tetsuya Watanabe, Akira Yamada, Masayoshi Yamamoto, Takashi Sozu, Masafumi Kitakaze
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Characterized by ventricular and vascular stiffness, heart failure with preserved ejection fraction (HFpEF) has led to high morbidity and mortality. As azilsartan is an angiotensin receptor blocker with the highest myocardial and vascular af
Externí odkaz:
https://doaj.org/article/2332815c35694fada98cbf50e45264af
Autor:
Raisuke Iijima, Masahide Tokue, Masato Nakamura, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 20 (2023)
Background Thrombocytopenia poses a risk of bleeding in patients with chronic coronary syndrome after coronary intervention. However, whether thrombocytopenia also increases the bleeding risk in patients with atrial fibrillation and chronic coronary
Externí odkaz:
https://doaj.org/article/be929cfe2d4e41b594590d0870ded8c3
Autor:
Masaaki Konishi, Eiichi Akiyama, Yasushi Matsuzawa, Ryosuke Sato, Shinnosuke Kikuchi, Hidefumi Nakahashi, Kozo Okada, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Toshihiro Misumi, Kouichi Tamura, Kazuo Kimura
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 732-737 (2023)
Abstract Aims Reduced skeletal muscle mass is a major component of sarcopenia, associated with impaired exercise capacity and poor prognosis in patients with heart failure (HF). Measurement of skeletal muscle mass by dual‐energy X‐ray absorptiome
Externí odkaz:
https://doaj.org/article/0b2f8cf48941453e893c797bcc54cb32
Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease
Autor:
Satoshi Yasuda, Hisao Ogawa, Masato Nakamura, Kenichi Tsujita, Atsushi Hirayama, Masaharu Akao, Junya Ako, Katsumi Miyauchi, Nobuhisa Hagiwara, Koichi Kaikita, Tetsuya Matoba, Kazuo Kimura, Kunihiko Matsui, Masanobu Ishii, Eiichiro Nishihara, Shinichiro Nakamura
Publikováno v:
Open Heart, Vol 10, Iss 1 (2023)
Objective Antithrombotic therapy is essential for patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) because of the high risk of thrombosis, whereas a combination of antiplatelets and anticoagulants is associated with a h
Externí odkaz:
https://doaj.org/article/ea4142eff3414ca794d5f720f1342ac4
Autor:
Kunihiko Matsui, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Hisao Ogawa
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background The success of antithrombotic therapies is assessed based on thrombotic and bleeding events. Simultaneously assessing both kinds of events might be challenging, and recurrent bleeding events are often ignored. We tried to confirm
Externí odkaz:
https://doaj.org/article/50982ce633024a68961295802ac4857f
Autor:
Shingo Kato, Kazuki Fukui, Sho Kodama, Mai Azuma, Naoki Nakayama, Tae Iwasawa, Kazuo Kimura, Kouichi Tamura, Daisuke Utsunomiya
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Background Coronary microvascular dysfunction (CMD) has been proposed as a novel mechanism for the pathophysiology of heart failure (HF) with preserved ejection fraction (HFpEF). Recent studies have suggested the potential utility of coronar
Externí odkaz:
https://doaj.org/article/fb615a6471d6448f874b56b8b55b9fb2
Autor:
Mitsuru Ishii, Masaharu Akao, Satoshi Yasuda, Koichi Kaikita, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 21 (2022)
Externí odkaz:
https://doaj.org/article/fc53bdc69c164fb482abe4f98ba704c9
Autor:
Shingo Kato, Kazuki Fukui, Sho Kodama, Mai Azuma, Naoki Nakayama, Tae Iwasawa, Kazuo Kimura, Kouichi Tamura, Daisuke Utsunomiya
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Background Phase-contrast cine cardiovascular magnetic resonance (CMR) of the coronary sinus has emerged as a non-invasive method to measure coronary sinus blood flow (CSBF) and coronary flow reserve (CFR). We aimed to compare the prognostic
Externí odkaz:
https://doaj.org/article/f5286c1617d8462db8cfbe535709fe2e
Autor:
Masaaki Konishi, Eiichi Akiyama, Yasushi Matsuzawa, Ryosuke Sato, Shinnosuke Kikuchi, Hidefumi Nakahashi, Nobuhiko Maejima, Noriaki Iwahashi, Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Toshihiro Misumi, Stephan vonHaehling, Stefan D. Anker, Kouichi Tamura, Kazuo Kimura
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 3, Pp 568-576 (2021)
Abstract Background Cachexia, characterized by loss of muscle with or without loss of fat mass, is a poor prognostic factor in patients with heart failure (HF). However, there is limited investigation on the prognostic impact of muscle and fat mass s
Externí odkaz:
https://doaj.org/article/af73026d02004981b6117ffec8da688e